The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir alafenamide in Treatment Experienced Patients

Abstract

Objective The primary outcome was to measure the proportion of patients experiencing DIs before and after the ART switch. The secondary outcome was to measure changes in DI scores before and after the ART switch.https://jdc.jefferson.edu/pharmacyposters/1021/thumbnail.jp